DexCom, Inc. (DXCM)
70.16
+0.19
(+0.27%)
USD |
NASDAQ |
Feb 09, 16:00
70.09
-0.07
(-0.10%)
After-Hours: 20:00
DexCom EPS Diluted (Quarterly) : 0.7035 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 1.017 |
| BioLife Solutions, Inc. | 0.0127 |
| Boston Scientific Corp. | 0.4493 |
| Krystal Biotech, Inc. | 2.660 |
| Insulet Corp. | 1.240 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 283.80M |
| Revenue (Quarterly) | 1.209B |
| Total Expenses (Quarterly) | 925.50M |
| Enterprise Value | 26.62B |
| Gross Profit Margin (Quarterly) | 61.80% |
| Profit Margin (Quarterly) | 23.47% |
| Earnings Yield | 2.56% |
| Operating Earnings Yield | 2.72% |
| Normalized Earnings Yield | 2.561 |